Benefits and limitations in using distortion product otoacoustic emissions to monitor for ototoxic hearing loss in paediatric oncology patients

---

Autoria(s): Beahan, N. M.; Kei, J.; Suppiah, R.; Young, J.; Triggs, T. E. J.; Charles, B. G.

Contribuinte(s)	Giulio J D'Angio
Data(s)	01/01/2002
Identificador	http://espace.library.uq.edu.au/view/UQ:62799
Publicador	John Wiley & Sons, Inc
Palavras-Chave	#CX #321025 Rehabilitation and Therapy - Hearing and Speech #730111 Hearing, vision, speech and their disorders
Tipo	Journal Article